Premium Ingredients
clinical dosages in every serving
Made in the USA
Following Certified Good Manufacturing Process Standards
GMO FREE
100% Natural Based Ingredients
Covidiol (Syrup)
Cannabidiol CBD + Cannabigerol CBG + Tetrahydrocannabinol THC + eucalyptus oil + Vitamins
Please read the complete product data sheet carefully before using Covidiol, as it contains essential information for your health. If you have any questions, consult your doctor. If you experience side effects, even those not listed in this document, consult your doctor immediately.
1. Viral respiratory infections: What to expect?
2. What is Covidiol?
3. Why Choose Covidiol?
4. Important Information Before Using Covidiol
5. How to Take Covidiol
6. Possible Side Effects
7. Storing Covidiol
8. Package Contents and Additional Information
9. Disclaimer
1. Viral respiratory infections: What to expect?
Respiratory viral infections are illnesses caused by viruses that specifically target cells in the respiratory tract, affecting areas such as the nose, throat, sinuses, and airways. These infections are highly contagious and can spread easily through respiratory droplets, posing a considerable global health threat due to their ability to cause widespread illness. Common respiratory viruses include influenza, respiratory syncytial virus (RSV), and coronaviruses like SARS-CoV-2, which have been responsible for significant outbreaks and pandemics.
These infections vary widely in severity, from mild symptoms like sore throat and cough to severe respiratory distress and pneumonia, particularly in vulnerable populations such as the elderly, young children, and people with weakened immune systems. Typical symptoms of respiratory viral infections include cough, fever, sore throat, fatigue, shortness of breath, and, in some cases, a loss of taste and smell. Severe cases can lead to hospitalization, and some individuals may experience prolonged symptoms, particularly following infections like COVID-19.
Treatment and prevention efforts include antiviral medications and vaccines, which are most effective when administered early in the course of illness. However, these efforts face challenges such as viral evolution, which can lead to resistance to antiviral drugs and necessitate frequent updates to vaccines. Vaccines remain a crucial tool in managing the spread and severity of respiratory viral infections, but ongoing research and development are essential to keep pace with viral mutations.
Globally, respiratory viral infections remain a major health concern, not only due to their high transmissibility but also because of their potential to cause severe illness and place significant strain on healthcare systems. Public health strategies, vaccination programs, and antiviral treatments are vital in managing and mitigating the impact of these infections on both individual and public health.
2. What is COVIDIOL?
Covidiol is an innovative formulation designed to provide comprehensive relief from the diverse and often debilitating symptoms of viral respiratory infections, including those caused by influenza, respiratory syncytial virus (RSV), adenovirus, and coronaviruses like SARS-CoV-2. By integrating advanced nanoplatforms for improved bioavailability, Covidiol ensures rapid and sustained relief from a wide range of symptoms such as persistent cough, fatigue, shortness of breath, pain, sore throat, nasal congestion, anosmia (loss of smell) and dysgeusia (loss of taste), lack of appetite, swollen tonsils, and mucus production.
Covidiol's effectiveness is rooted in its unique combination of active ingredients: cannabinoids including Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Cannabigerol (CBG), along with eucalyptus oil and essential vitamins (C, B9, and B12). These components work synergistically through the endocannabinoid system, which plays a key role in regulating immune response, inflammation, and respiratory function. By targeting this system, Covidiol not only addresses immediate symptoms but also supports the body’s natural defenses, helping reduce inflammation and promote overall respiratory health.
This multi-targeted approach makes Covidiol a powerful tool for symptom management in viral respiratory infections. Its unique formulation offers potential not only for immediate symptom relief but also for enhancing long-term respiratory health, minimizing health risks, and improving overall quality of life for individuals affected by these widespread infections.
3. Why Covidiol?
This formulation utilizes nanoemulsion technology to enhance the bioavailability and therapeutic efficacy of cannabinoids and other active ingredients, allowing faster absorption and improved therapeutic outcomes. The endocannabinoid system (ECS) plays a vital role in regulating homeostasis and immune responses, making it particularly relevant for treating viral respiratory infections.
CB1 receptors, primarily located in the nervous system, may protect against airway inflammation, while CB2 receptors in lung cells are critical for immune responses. Cannabinoids can modulate these responses, inhibiting mast cell activation and regulating cytokine production, which is crucial during viral infections.
Cannabidiol (CBD) has shown promise in managing conditions like COVID-19 by reducing inflammation and inhibiting viral replication, making it a valuable complementary treatment. Cannabigerol (CBG) also demonstrates antiviral properties and can modulate immune responses, further supporting its use in respiratory infections.
Eucalyptus oil, particularly due to its active component eucalyptol, has shown promise in managing viral respiratory infection symptoms through its anti-inflammatory, antiviral, and antimicrobial properties. It has been demonstrated to inhibit the proliferation of various viruses, including herpes simplex, influenza A (H1N1), rotavirus, and coxsackie virus, among others. These properties highlight the potential of eucalyptus oil as a complementary therapeutic option in managing respiratory infections.
Vitamins C, B12, and B9 may each offer protective effects against respiratory infections and coronaviruses. Vitamin C can reduce the severity and duration of respiratory infections by enhancing immune functions and boosting antioxidant defenses. Vitamin B12 shows potent antiviral activity against coronaviruses inhibiting viral replication, reducing viral loads, and protecting cells from cytopathic effects, highlighting its potential in antiviral strategies. Additionally, Vitamin B9 (folic acid) may influence viral replication, immune response, and inflammation in SARS-CoV-2 infection (Karakousis et al., 2023). Together, these vitamins could contribute to both immune support and antiviral defense.
Choosing this formulation for treating viral respiratory infections is important because it combines effective cannabinoids, essential oils, and advanced delivery technology, enhancing therapeutic benefits and supporting immune function, ultimately promoting faster recovery and improved patient outcomes.
4. Important Information Before Using Covidiol
Consult your doctor if:
-
You are taking other medications, especially those metabolized by the liver (e.g., anticoagulants, antiepileptics, antidepressants).
-
You are pregnant or breastfeeding, as the safety of cannabinoids during these periods is not fully established. Therefore, it is recommended to avoid use in these periods unless indicated by a physician on a risk-benefit basis.
-
You have pre-existing medical conditions, such as liver, kidney, or cardiovascular diseases.
Do not take Covidiol if:
-
If you are allergic to cannabinoids, specifically CBD, THC, CBG, or any of the other components of this product.
-
If you are taking beta-blocker drugs such as metoprolol it may potentiate the mechanism of action of the drug inducing hypotension, dizziness, and weakness.
5. How to take Covidiol?
-
Follow your doctor's instructions and the product label for dosage.
-
Administered orally
-
Do not exceed the recommended dosage: take one tablespoon every 12 hours (morning and evening) for a duration of 2 weeks.
If you accidentally take more than the recommended dose, seek medical help immediately. Symptoms of overdose include nausea, vomiting, seizures, heart problems (such as irregular heartbeat or cardiac arrest), lung conditions, and altered mental status.
Recommendations:
-
If you miss a dose, don’t worry. Simply take your next dose at the regular scheduled time the following day. Avoid doubling up on doses to make up for the missed one.
-
To help you remember, try to take Covidiol at the same time each day.
-
Do not discontinue Covidiol without consulting your doctor, even if you begin to feel better. Consistent use is important for maintaining its therapeutic effects.
-
If you have any questions or concerns about how to use this product, consult your doctor.
6. Possible side effects
-
If you experience a skin rash or any allergic reactions such as itching, swelling of the lips or tongue, wheezing, or difficulty breathing, stop using the product immediately and seek medical advice as soon as possible.
-
Common side effects (affecting more than 1 in 10 people) may include insomnia, headaches, diarrhea, nausea, and fatigue.
-
Rare side effects may include elevated liver enzymes (AST, ALT, GGT), seizures, status epilepticus, gait disturbances, or abnormal behavior.
Reporting of adverse effects:
If you experience any type of adverse effect, consult your doctor, even if it is not listed in this datasheet. You can also communicate directly via email: rd@cbih.net
By reporting adverse effects you can contribute to providing more information about the safety of this product.
7. Storage of Covidiol
-
Keep this product out of the sight and reach of children.
-
Do not use this product after the expiration date stated on the package. The expiration date is the last day of the month indicated.
-
Store Covidiol at a temperature below 30 ºC.
8. Package contents and additional information
Covidiol:
The active ingredients are THC at 3 mg, CBD at 10 mg, and CBG at 10 mg, combined with 600 mg of Vitamin C, 0.133 mg of Vitamin B9, and 0.0008 mg of Vitamin B12.
The other ingredients are medium-chain triglycerides (MCT) and alpha-tocopherol.
Appearance of the product and package contents:
The syrup is a 250 mL jar with a shiny surface and amber color.
9. Disclaimer
The information provided here is based on extensive research conducted to develop Covidiol and its proposed mechanisms of action. However, this information is intended for informational purposes only and does not constitute medical advice.
These statements and products have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Marketing Authorization Holder and Responsible for Manufacture.
Holder: Cannabis Bioscience International Holdings
